Abstract:OBJECTIVE To investigate the relationship between contents of blood somatostatin (SST) and inflammatory reaction or severity of illness in critically ill patients, and its value in the evaluation of prognosis. METHODS Sixty critically ill patients were divided into three groups according to the acute physiology and chronic health evaluation II (APACHE II) score as mild (<16, 23 cases), mediate (16 - 20, 20 cases) and severe (>20, 17 cases) group; and also divided as dead (D, 13 cases) or survival group (S, 47 cases) according to the final outcome; 20 healthy volunteers served as control. The blood SST concentration was detected by radioimmunoassay, while the levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) were measured by enzyme linked immunosorbent assay (ELISA). RESULTS The SST concentration in critically ill patients was significantly lower than normal control [(18.2+/-17.6) ng/L vs. (224.8+/-130.2) ng/L, P<0.05], while the levels of TNF-alpha and IL-6 were significantly higher [TNF-alpha: (32.4+/-14.2) ng/L vs. (14.2+/-5.7) ng/L, IL-6: (131.6+/- 42.7) ng/L vs. (65.8+/-24.3) ng/L, both P<0.05]. The SST concentration in severe group was significantly lower than that of mild and mediate group [(8.1+/-7.2) ng/L vs. (24.7+/-15.9) ng/L and (19.2+/-22.1) ng/L, both P<0.05], while the levels of TNF-alpha and IL-6 were significantly higher than mild group [TNF-alpha: (39.0+/-16.4) ng/L vs. (28.9+/-10.9) ng/L, IL-6: (156.0+/-49.6) ng/L vs. (111.5+/-32.6) ng/L, both P<0.05]. A negative correlation was found between SST and TNF-alpha, IL-6, also between SST and APACHE II score (r(1)=-0.682, r(2)=-0.894, r(3)=-0.327, P<0.05 or P<0.01). The SST concentration in D group was significantly lower than S group [(6.4+/-5.5) ng/L vs. (21.5+/-18.4) ng/L, P<0.05]. CONCLUSION The SST level in blood can reflect the severity of illness in critically ill patients and shows clinical value in evaluation of prognosis.

Progresses of Somatostatin Quantification for Clinical Practice

Quantification of somatostatin with a surface plasmon resonance-based biosensor

Affinity Analysis of Somatostatin and Somatostatin Receptor by Surface Plasmon Resonance

Somatostatin Receptor Based Imaging and Radionuclide Therapy

Real-time evaluation of somatostatin subtype 2 receptor activity employing the technique of cytosensor microphysiometry

New Method for Quantification of Gasotransmitter Hydrogen Sulfide in Biological Matrices by LC-MS/MS

High-throughput receptor-binding methods for somatostatin receptor 2

[Clinical Implication of Blood Somatostatin Determination in Critically Ill Patients].

Study on design and application of fully automatic miniature surface plasmon resonance concentration analyzer

Direct-S: a directed mass spectrometry method for biomarker verification in native serum.

Growth stimulation expressed gene 2 (ST2): Clinical research and application in the cardiovascular related diseases

Influence of Segmental and Selected Ion Monitoring on Quantitation of Multi-Component Using High-Pressure Liquid Chromatography–quadrupole Mass Spectrometry: Simultaneous Detection of 16 Saponins in Rat Plasma As a Case

Sensitive quantification of the somatostatin analog AP102 in plasma by ultra-high pressure liquid chromatography-tandem mass spectrometry and application to a pharmacokinetic study in rats

Expression of Somatostatin Receptors in Human Pancreatic Tumor

Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4

PK study of octreotide based on LC-MS/MS combining protein precipitation and impurity extraction technique.

Relative Quantitative Analysis of Human Plasma O‑sulfotyrosine Using HPLC‑MS/MS in Linear Negative Ion Mode

In silico Study on the Binding Interactions of SSTA and 18F-SSTA Towards Somatostatin Receptor Subtype 2

Liquid Chromatography/Tandem Mass Spectrometry Method for Quantification of Trans-Stilbene Glycoside in Rat Plasma and Its Pharmacokinetic Application

Determination of sodium tanshinone IIA sulfonate in plasma by liquid chromatography-electrospray ionisation-tandem mass spectrometry.

Development, validation and comparison of four methods for quantifying endogenous 25OH-D3 in human plasma